James Shaw is a consultant diabetes specialist in Newcastle in the UK. He is dedicated to providing personalised care and support to people living with diabetes. This includes the hypoglycaemia risk reduction mentorship programme he designed – My Hypo Compass. He leads the Newcastle pancreatic islet transplant programme and chairs the UK Islet Transplant Consortium, Quality in Organ Donation Steering Committee and the type 1 diabetes Research Steering Group for Diabetes UK. He is a lead investigator for an ongoing clinical trial evaluating insulin-producing islets manufactured from stem cells.
He is Professor of Regenerative Medicine at Newcastle University where he has created a tissue bank including 150 pancreas organs enabling ground-breaking research towards transformative new diabetes therapies. His lab group are currently focused on understanding the pathways through which scarring processes in the exocrine pancreas lead to diabetes paving the way to trials using ‘anti-fibrotic’ drug therapy to restore endogenous pancreatic insulin production.